Business Context and Reporting Period
Company: Jackson Financial Inc. (JFI)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Overview: Jackson Financial is a U.S. financial services company focused on retirement savings and income solutions, primarily through annuities. The company operates through three reportable segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks. In 2024, the company executed a significant reinsurance transaction with its captive subsidiary, Brooke Re, to optimize hedging and stabilize capital generation.
Key Financial Metrics
| Metric (in millions, except %) | 2024 | 2023 |
|---|---|---|
| Total Sales | $19,849 | $13,898 |
| Assets Under Management (AUM) | $324,718 | $315,838 |
| Net Income (GAAP) to Common Shareholders | $902 | $899 |
| Adjusted Operating Earnings (Non-GAAP) | $1,443 | $1,073 |
| Return on Equity (ROE) to Common Shareholders | 9.4% | 10.3% |
| Adjusted Operating ROE | 12.9% | 10.6% |
| Risk-Based Capital (RBC) Ratio | 572% | 624% |
| Capital Returned to Shareholders | $631 | $464 |
Note: The filing text does not provide a specific "Revenue" line item distinct from "Total Revenues" in the income statement, which was $3,271 million for 2024. The company emphasizes "Total Sales" and "Adjusted Operating Earnings" as primary performance indicators.
Material Changes vs. Prior Period
- Sales Growth: Total sales increased 43% to $19.8 billion, driven primarily by a 96% increase in Registered Index-Linked Annuity (RILA) sales ($5.7 billion) and a 642% increase in Fixed Annuity sales ($1.4 billion) as consumers sought to lock in rates.
- Net Flows: Retail annuity net flows were negative $11.7 billion (net of reinsurance), compared to negative $6.3 billion in 2023. This was driven by increased variable annuity surrenders as policies exited surrender charge periods and strong equity markets made guarantees less "in-the-money."
- Profitability: Adjusted Operating Earnings increased 35% to $1.44 billion, reflecting higher fee income from increased account values and improved spread income, partially offset by higher commission expenses.
- Reinsurance Transaction: In Q1 2024, Jackson entered a 100% coinsurance transaction with Brooke Re. This transaction ceded market risk benefits liabilities, allowing for more efficient economic hedging and mitigating the impact of the cash surrender value floor on statutory capital.
Guidance, Outlook, and Risks
Guidance and Outlook
- Capital Return: The company targets returning $700 million to $800 million to common shareholders in 2025.
- Free Capital Generation: Management expects free capital generation to exceed $1 billion in 2025 under normal market conditions.
- Dividends: A quarterly common dividend of $0.80 per share was declared for Q1 2025 (up from $0.70 in 2024).
Risks and Contingencies
- Market Risk: Significant exposure to equity market movements and interest rate fluctuations. Rising rates can lead to disintermediation (policyholder lapses) and hedging losses, while falling rates can compress investment spreads.
- Regulatory Environment: The company faces uncertainty regarding the Department of Labor's 2024 Fiduciary Advice Rule, which is currently stayed pending litigation but could impact compensation practices and product offerings.
- Cybersecurity: The company faces evolving cyber threats; however, no material cybersecurity events were reported in 2024.
- Reinsurance Counterparty Risk: Significant concentration of credit risk exists with Athene Life Re Ltd., which reinsures the majority of fixed and fixed index annuity liabilities.
Key Facts for Investor Verification
- Reinsurance Structure: Verify the long-term impact of the Brooke Re transaction on statutory capital stability and hedging efficiency.
- Net Flow Trends: Monitor the sustainability of negative net flows in the variable annuity segment and the ability of RILA/Fixed sales to offset these outflows.
- Regulatory Capital: Confirm that the RBC ratio remains well above the "Company Action Level" (75%) despite the decline from 624% to 572%.
- Share Repurchases: Track the execution of the remaining $568 million share repurchase authorization as of February 2025.
- Actuarial Assumptions: Review the annual actuarial assumption updates, which resulted in a $26 million loss to Adjusted Operating Earnings in 2024, primarily due to mortality table updates in the Closed Life segment.